Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan 17;4(1):100909.
doi: 10.1016/j.xcrm.2022.100909.

Proteome-based insights for IDH-mutant glioma classification

Severina Leu  1 , Gregor Hutter  1 , Jean-Louis Boulay  2
Affiliations
Comment

Proteome-based insights for IDH-mutant glioma classification

Severina Leu et al. Cell Rep Med. .

Abstract

In this issue, Bader et al.1 characterize the proteomes of diffuse glioma brain tumors by liquid chromatography mass spectrometry and classify isocitrate dehydrogenase (IDH)-mutant gliomas into two subtypes, which differ in oncogenic pathways and aerobic/anaerobic energy metabolism.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The author declares no competing interests.

Comment on

References

    1. Bader J., Deigendesch N., Misch M., Mann M., Koch A., Meissner F. Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status. Cell Reports Medicine. 2022;4:100877-1–100877-22. - PMC - PubMed
    1. Scherer H.J. A CRITICAL REVIEW: the PATHOLOGY OF CEREBRAL gliomas. J Neurol Psychiatry. 1940;3:147–177. doi: 10.1136/jnnp.3.2.147. - DOI - PMC - PubMed
    1. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G.J., et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 2009;360:765–773. doi: 10.1056/nejmoa0808710. - DOI - PMC - PubMed
    1. Bigner S.H., Matthews M.R., Rasheed B.K., Wiltshire R.N., Friedman H.S., Friedman A.H., Stenzel T.T., Dawes D.M., McLendon R.E., Bigner D.D. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol. 1999;155:375–386. - PMC - PubMed
    1. Leu S., von Felten S., Frank S., Vassella E., Vajtai I., Taylor E., Schulz M., Hutter G., Hench J., Schucht P., et al. IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival. Neuro Oncol. 2013;15:469–479. doi: 10.1093/neuonc/nos317. - DOI - PMC - PubMed